π
|
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
26 auth.
B. Celli,
W. Macnee,
A. AgustΓ,
A. Anzueto,
B. Berg,
A. Buist,
P. Calverley,
N. Chavannes,
T. Dillard,
Bonnie F. Fahy,
A. Fein,
J. Heffner,
S. Lareau,
P. Meek,
F. Martinez,
...
W. McNicholas,
J. Muris,
E. Austegard,
R. Pauwels,
S. Rennard,
A. Rossi,
N. Siafakas,
B. Tiep,
J. Vestbo,
E. Wouters,
R. Zuwallack
|
12 |
2004 |
12 π
|
π
|
ERS statement on respiratory muscle testing at rest and during exercise
25 auth.
P. Laveneziana,
A. Albuquerque,
A. Aliverti,
T. Babb,
E. Barreiro,
M. Dres,
B. DubΓ©,
B. Fauroux,
J. Gea,
J. Guenette,
Anna L. Hudson,
H. Kabitz,
F. Laghi,
D. Langer,
Yuan-ming Luo,
...
J. A. Neder,
Denis E. OβDonnell,
M. Polkey,
R. Rabinovich,
A. Rossi,
F. Sériès,
T. Similowski,
C. Spengler,
I. Vogiatzis,
S. Vergès
|
8 |
2019 |
8 π
|
π
|
The Italian multicentre study on noninvasive ventilation in chronic obstructive pulmonary disease patients
7 auth.
E. Clini,
C. Sturani,
A. Rossi,
S. Viaggi,
A. Corrado,
C. Donner,
...
N. Ambrosino
|
8 |
2002 |
8 π
|
π’
|
A chart of failure risk for noninvasive ventilation in patients with COPD exacerbation
11 auth.
M. Confalonieri,
G. Garuti,
M. Cattaruzza,
J. Osborn,
M. Antonelli,
G. Conti,
...
M. Kodric,
O. Resta,
S. Marchese,
C. Gregoretti,
A. Rossi
|
8 |
2005 |
8 π’
|
π
|
Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns
11 auth.
D. Price,
D. West,
G. Brusselle,
K. Gruffydd-Jones,
Rupert C Jones,
M. Miravitlles,
...
A. Rossi,
C. Hutton,
Valerie L. Ashton,
Rebecca Stewart,
K. Bichel
|
8 |
2014 |
8 π
|
π’
|
Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD.
D. Price,
B. Yawn,
G. Brusselle,
A. Rossi
|
7 |
2012 |
7 π’
|
π’
|
How far is real life from COPD therapy guidelines? An Italian observational study.
A. Corrado,
A. Rossi
|
7 |
2012 |
7 π’
|
π¦
|
INSTEAD: a randomised switch trial of indacaterol versus salmeterol/fluticasone in moderate COPD
11 auth.
A. Rossi,
T. van der Molen,
R. Olmo,
A. Papi,
L. Wehbe,
M. Quinn,
...
Chengxing Lu,
David Young,
R. Cameron,
E. Bucchioni,
P. Altman
|
7 |
2014 |
7 π¦
|
π¦
|
Withdrawal of inhaled corticosteroids can be safe in COPD patients at low risk of exacerbation: a real-life study on the appropriateness of treatment in moderate COPD patients (OPTIMO)
A. Rossi,
M. Guerriero,
A. Corrado
|
7 |
2013 |
7 π¦
|
π¦
|
Mechanisms, assessment and therapeutic implications of lung hyperinflation in COPD.
11 auth.
A. Rossi,
Z. Aisanov,
S. Avdeev,
G. D. Di Maria,
C. Donner,
J. Izquierdo,
...
N. Roche,
T. Similowski,
H. Watz,
H. Worth,
M. Miravitlles
|
7 |
2015 |
7 π¦
|
π
|
Asthma, COPD and overlap syndrome: a longitudinal study in young European adults
15 auth.
R. de Marco,
A. Marcon,
A. Rossi,
J. AntΓ³,
I. Cerveri,
T. Gislason,
J. Heinrich,
C. Janson,
D. Jarvis,
N. Kuenzli,
...
B. Leynaert,
N. Probst-Hensch,
C. Svanes,
M. Wjst,
P. Burney
|
7 |
2015 |
7 π
|
π’
|
Treatment strategies for asthma: reshaping the concept of asthma management
A. Papi,
F. Blasi,
G. Canonica,
L. Morandi,
L. Richeldi,
A. Rossi
|
6 |
2020 |
6 π’
|